Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Dr. Jennifer Sheng – Johns Hopkins Cancer Center

Name: Dr. Jennifer Sheng – Johns Hopkins Cancer Center
Uploaded: 2021-12-01
Duration: 52 s
Description: Testimonial detailing her experience publishing with Oncotarget in Volume 12, Issue 6

Dr. Jennifer Sheng from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center shares her experience publishing "Innovating and expanding weight loss strategies for breast cancer survivors" with Oncotarget.

—

Listen to an audio version of this post

Dr. Jennifer Sheng

"We are really appreciative of Oncotarget accepting our piece and just sharing our thoughts, not just about our study, but also some of the future innovations that lay ahead.

The process was really quite simple and we got great feedback from our editorial with the reviewers as well.

I hope to share future editorials with you all in the future."

Click here to read the full study published by Oncotarget.

View more testimonials here

ONCOTARGET VIDEOS: YouTube | LabTube | Oncotarget.com

—

Oncotarget is a unique platform designed to house scientific studies in a journal format that is available for anyone to read without a paywall making access more difficult. This means information that has the potential to benefit our societies from the inside out can be shared with friends, neighbors, colleagues, and other researchers, far and wide.

For media inquiries, please contact [email protected].

Publication Alerts

Dr. Jennifer Sheng – Johns Hopkins Cancer Center